Preoperative treatment for marginally resectable metastatic melanoma: A single center experience in China.

e22096Background: Large randomized trials have proved that targeted therapy (TT) and immunotherapy (IT) can improve RFS for resectable Stage III melanoma. However, there is still a risk around 15%~...